IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 64
Titolo Data di pubblicazione Autore(i) File
Hereditary breast/ovarian cancer families: The impact of mutation prediction models on BRCA1/2 mutation screening costs. 1-gen-2006 C., Capalbo; E., Ricevuto; P., Marchetti; Adamo, Barbara; Adamo, Vincenzo; A., Vestri; L., Frati; I., Screpanti; A., Gulino; G., Giannini
Neoplasie della testa collo nell’ anziano 1-gen-2006 Adamo, Vincenzo; Ferraro, Giuseppa; Scandurra, G; Adamo, Barbara; Franchina, Tindara
Strategia Terapeutica nel Carcinoma Prostatico Ormonorefrattario 1-gen-2006 Adamo, Vincenzo; Rosalba, Rossello; Adamo, Barbara; Nicola, Caristi; Gianluca, Spitaleri; Antonino, Scimone
Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care. 1-gen-2006 Adamo, Vincenzo; Ferraro, Giuseppa; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy. 1-gen-2006 Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; Scandurra, G; Scimone, Andrea
Safety and clinical activity of trastuzumab (TSM) containing therapies in heavily pretreated patients with metastatic breast cancer (MBC): A five-year experience 1-gen-2007 Adamo, Barbara; Franchina, Tindara; R., Rossello; Garipoli, Claudia; M., Iorfida; V., Festa; E., Montalto; M., Valerio; A., Russo; Adamo, Vincenzo
Safety of Zoledronic acid in bone metastatic breast cancer patients: A retrospective analysis. 1-gen-2007 Ferraro, G; Caristi, N; MAUGERI SACCÀ, M; Arcanà, C; Adamo, Barbara; Briguglio, R; Zanghi', Mariangela; Adamo, V.
Safety and activity of trastuzumab (TRA) containing therapies as treatment of metastatic breast cancer(MBC): a five year experience. 1-gen-2007 R., Rossello; Adamo, Barbara; Franchina, Tindara; Garipoli, Claudia; M., Iorfida; V., Festa; E., Montalto; M. R., Valerio; A., Russo; Adamo, Vincenzo
Safety of the combination Capecitabine plus Bevacizumab in the treatment of heavily treated advanced colorectal cancer patients: Our experience. 1-gen-2007 Adamo, Vincenzo; Vincenzo, Festa; Adamo, Barbara; Franchina, Tindara; Monica, Iorfida; MARCELLO MAUGERI, Sacca'; Erika, Montalto; Rosalba, Rossello; AND GIAMPAOLO, Tortora
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study) 1-gen-2007 ADAMO V.; FRANCHINA T; ADAMO B; FERRARO G; ROSSELLO R; MAUGERI SACCA' M; SCIBILIA C; VALERIO MR; RUSSO A
Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels 1-gen-2008 Prat, A; Parera, M; Adamo, Barbara; Peralta, S; PEREZ BENAVENTE, Ma; Garcia, A; GIL MORENO, A; MARTINEZ PALONES, Jm; Baselga, J; DEL CAMPO, Jm
A rare case of malignant solitary fibrous tumor of the spinal cord 1-gen-2008 Muñoz, E; Prat, A; Adamo, Barbara; Peralta, S; RAMÓN Y., CAJAL S; Valverde, C.
Prognostic significance of elevated pretreatment serum CA-125 in patients (pts) with epithelial ovarian cancer (CEO) treated with surgery and platinum/taxane-based chemotherapy. 1-gen-2008 A., Prat; M., Parera; S., Peralta; P., Martìnez; Adamo, Barbara; M., PÈREZ BENAVENTE; A., GIL MORENO; A., Garcia; J., MARTÌNEZ PALONES; J., Baselga
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience. 1-gen-2008 Franchina, Tindara; A., Scimone; Adamo, Barbara; N., Denaro; P., Gambadauro; M., Iorfida; Caristi, Nicola; Zanghi', Mariangela; Adamo, Vincenzo
Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data. 1-gen-2008 Adamo, Vincenzo; Franchina, Tindara; Adamo, Barbara; R., Briguglio; E., Restuccia; G., Chiofalo; Ferraro, Giuseppa; Caccamo, Daniela; R., Ientile
SAFETY AND ACTIVITY OF ERLOTINIB (TARCEVA) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC, REFRACTORY NON SMALL CELL LUNG CANCER 1-gen-2008 Franchina, Tindara; Denaro, N; Gambadauro, P; Adamo, Barbara; MAUGERI SACCA', M; Maisano, C; Scimone, A; Adamo, Vincenzo
SAFETY OF PEGILATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ELDERLY WOMEN (>65 YEARS)WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER 1-gen-2008 Adamo, Barbara; Iorfida, M; Condemi, G; Garipoli, Claudia; Ferraro, Giuseppa; Montalto, E; Pastura, G; Ferrandina, G; Adamo, Vincenzo
Simultaneous development and parallel course of disseminated superficial porokeratosis and ovarian cancer: Coincidental association or true paraneoplastic syndrome? 1-gen-2008 Cannavo', Serafinella; Borgia, Francesco; Adamo, Barbara; Guarneri, Biagio
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study. 1-gen-2008 Adamo, Vincenzo; Lorusso, V; Rossello, R; Adamo, Barbara; Ferraro, Giuseppa; Lorusso, D; Condemi, G; Priolo, D; DI LULLO, L; Paglia, A; Pisconti, S; Scambia, G; Ferrandina, G.
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes. 1-gen-2009 Ieni, Antonio; Simone, Angela; G., Neri; Barresi, Valeria; Giuffre', Giuseppe; Adamo, Barbara; Caristi, Nicola; Colonese, Francesca; Gioffre', Maria; Adamo, Vincenzo; Tuccari, Giovanni
Mostrati risultati da 21 a 40 di 64
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile